Department of Physical Medicine and Rehabilitation, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.
Center for Value-Based Care Research, Cleveland Clinic, Cleveland, OH, USA.
Trials. 2023 Jul 24;24(1):471. doi: 10.1186/s13063-023-07501-y.
Hospitalized older adults spend as much as 95% of their time in bed, which can result in adverse events and delay recovery while increasing costs. Observational studies have shown that general mobility interventions (e.g., ambulation) can mitigate adverse events and improve patients' functional status. Mobility technicians (MTs) may address the need for patients to engage in mobility interventions without overburdening nurses. There is no data, however, on the effect of MT-assisted ambulation on adverse events or functional status, or on the cost tradeoffs if a MT were employed. The AMBULATE study aims to determine whether MT-assisted ambulation improves mobility status and decreases adverse events for older medical inpatients. It will also include analyses to identify the patients that benefit most from MT-assisted mobility and assess the cost-effectiveness of employing a MT.
The AMBULATE study is a multicenter, single-blind, parallel control design, individual-level randomized trial. It will include patients admitted to a medical service in five hospitals in two regions of the USA. Patients over age 65 with mild functional deficits will be randomized using a block randomization scheme. Those in the intervention group will ambulate with the MT up to three times daily, guided by the Johns Hopkins Mobility Goal Calculator. The intervention will conclude at hospital discharge, or after 10 days if the hospitalization is prolonged. The primary outcome is the Short Physical Performance Battery score at discharge. Secondary outcomes are discharge disposition, length of stay, hospital-acquired complications (falls, venous thromboembolism, pressure ulcers, and hospital-acquired pneumonia), and post-hospital functional status.
While functional decline in the hospital is multifactorial, ambulation is a modifiable factor for many patients. The AMBULATE study will be the largest randomized controlled trial to test the clinical effects of dedicating a single care team member to facilitating mobility for older hospitalized patients. It will also provide a useful estimation of cost implications to help hospital administrators assess the feasibility and utility of employing MTs.
Registered in the United States National Library of Medicine clinicaltrials.gov (# NCT05725928). February 13, 2023.
住院的老年患者在病床上的时间高达 95%,这可能导致不良事件和康复延迟,同时增加成本。观察性研究表明,一般的活动干预(如走动)可以减轻不良事件并改善患者的功能状态。活动技术员(MT)可以满足患者进行活动干预的需求,而不会给护士带来过重的负担。然而,目前尚无关于 MT 辅助活动对不良事件或功能状态的影响,或者如果雇用 MT 会产生什么样的成本效益权衡的相关数据。AMBULATE 研究旨在确定 MT 辅助活动是否能改善老年内科住院患者的活动能力状况并减少不良事件。它还将包括分析,以确定最受益于 MT 辅助活动的患者,并评估雇用 MT 的成本效益。
AMBULATE 研究是一项多中心、单盲、平行对照设计、个体水平随机试验。它将包括在美国两个地区的五家医院的内科病房住院的患者。年龄在 65 岁以上、有轻度功能缺陷的患者将采用分组随机化方案进行随机分组。干预组的患者将在 MT 的指导下,每天最多进行三次走动,MT 将根据约翰霍普金斯活动目标计算器进行指导。干预将在患者出院时结束,如果住院时间延长,则在 10 天后结束。主要结果是出院时的简短身体表现电池评分。次要结果是出院处置、住院时间、医院获得性并发症(跌倒、静脉血栓栓塞、压疮和医院获得性肺炎)以及出院后的功能状态。
虽然医院内的功能下降是多因素的,但活动是许多患者可改变的因素。AMBULATE 研究将是最大规模的随机对照试验,旨在测试专门指定一名护理团队成员为老年住院患者提供活动便利的临床效果。它还将提供对成本影响的有用估计,以帮助医院管理人员评估雇用 MT 的可行性和实用性。
在美国国家医学图书馆临床试验注册处注册(#NCT05725928)。2023 年 2 月 13 日。